www.fdanews.com/articles/184187-alcyone-wins-ce-mark-for-alivio-ventricular-catheter-and-flusher-system
![Purple_Approved_Stamp.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/Purple_Approved_Stamp.gif?t=1576639773&width=430)
Alcyone Wins CE Mark for Alivio Ventricular Catheter and Flusher System
October 31, 2017
Alcyone Lifesciences received a CE Mark for its Alivio Ventricular Catheter and Flusher System for the treatment of Hydrocephalus.
The shunts are implantable devices inserted by neurosurgeons to treat hydrocephalus, a condition in which an excess of cerebrospinal fluid accumulates in the ventricles and can increase intracranial pressure in the brain, creating a potentially life-threatening condition.
The system, in conjunction with any CSF shunt, is designed to unblock ventricular catheters.